(Q42751622)

English

P3Kα: a driver of tumor metastasis?

scientific article published on September 2010

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

6 November 2017

P3Kα: a driver of tumor metastasis? (English)

1 reference

stated in

Europe PubMed Central

6 November 2017

1 reference

Leigh Zawel

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3157728

retrieved

6 November 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

stated in

Europe PubMed Central

6 November 2017

1 reference

Europe PubMed Central

6 November 2017

1

1 reference

stated in

Europe PubMed Central

6 November 2017

5

1 reference

stated in

Europe PubMed Central

6 November 2017

315-316

1 reference

stated in

Europe PubMed Central

6 November 2017

PI3Kα inhibitors that inhibit metastasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157728

retrieved

27 May 2018

The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157728

retrieved

27 May 2018

In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157728

retrieved

27 May 2018

Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157728

retrieved

27 May 2018

NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157728

retrieved

27 May 2018

Cancer-specific mutations in phosphatidylinositol 3-kinase

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157728

retrieved

27 May 2018

PI3K regulatory subunits lose control in cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157728

retrieved

16 August 2018

Identifiers

PMC publication ID

3157728

1 reference

stated in

Europe PubMed Central

PMC publication ID

3157728

retrieved

6 November 2017

PubMed publication ID

21307397

1 reference

stated in

Europe PubMed Central

PMC publication ID

3157728

retrieved

6 November 2017

(Q42751622)

P3Kα: a driver of tumor metastasis?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)